ADDvise Group acquires MRC Systems FZE - Regulatory information

16-02-2021   Regulatory press release

ADDvise Group AB (publ) ("ADDvise") has entered into a share purchase agreement with the shareholders of MRC Systems FZE (the "Company" and "MRC") regarding an acquisition of 100 percent of the shares in the Company (the "Acquisition").

MRC develops and manufactures cleanrooms for the pharmaceutical industry and hospitals. The Company has its headquarters and production facility located in Dubai. The Company currently employs around 110 people.

The initial purchase price amounts to USD 5 million. In addition to the initial purchase price, additional earn-outs of maximum USD 3 million in total can be paid out over a three-year period, given that the sellers achieve certain predetermined targets.

The Company's revenue for the financial year 2019/2020 amounts to USD 9.8 million with an EBITDA of USD 1.10 million. Proforma revenue 2020 for ADDvise including MRC will therefore amount to approximately SEK 439.6 million with an EBITDA of approximately SEK 55.0 million. The Acquisition is financed with own funds.

The closing of the acquisition is expected to take place during the second quarter of 2021, subject to the conditions precedent to closing are met.

Adviser

Mangold Fondkommission AB has acted as financial adviser to ADDvise in the Acquisition. DLA Piper Middle East LLP has acted as legal adviser to ADDvise in the Acquisition.  

For further information, please contact:

Rikard Akhtarzand, VD
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se

Important information:

This information is by ADDvise Group AB required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on 16 February 2021 at 15:00 CET.
 

Om ADDvise Group
ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business - both geographically and product wise. ADDvise Group's shares are listed on Nasdaq First North Growth Market and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se,is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.

Latest press releases

ADDvise completes the acquisition of MRC Systems FZE

Regulatory

ADDvise Group AB (publ) (”ADDvise”) has today completed the acquisition of all shares in MRC Systems FZE (”MRC”). The signing of the share purchase agreement has been communicated to the market via a press release on 16 February 2021. The total purchase price amounts to USD 8.00 million, of which USD 4.50 million has been…

ADDvise signs Letter of Intent to acquire Medisuite, LLC

Regulatory

ADDvise Group AB (publ) has signed a Letter of Intent with the shareholders of Medisuite, LLC (”Medisuite”) regarding an acquisition of 100 percent of the shares in Medisuite. Medisuite is an American online pharmacy that specializes in medication for men’s health. The prescription medication that is marketed by Medisuite is mainly used for treatment of…

ADDvise Group to redeem its outstanding up to SEK 240,000,000 senior secured callable bonds

Regulatory

ADDvise Group AB (publ) (“ADDvise") hereby announces that ADDvise’s up to SEK 240,000,000 senior unsecured callable floating rate bonds with ISIN SE0010298166 (the "Bonds"), will be redeemed in advance in accordance with Clause 8.3 (Voluntary total redemption (call option)) of the terms and conditions of the Bonds. The redemption date will be 18 June 2021.…